Journal article
CD8 T cells utilize TRAIL to control influenza virus infection
The Journal of immunology (1950), Vol.181(7), pp.4918-4925
10/01/2008
DOI: 10.4049/jimmunol.181.7.4918
PMCID: PMC2610351
PMID: 18802095
Abstract
Elimination of influenza virus-infected cells during primary influenza virus infections is thought to be mediated by CD8(+) T cells though perforin- and FasL-mediated mechanisms. However, recent studies suggest that CD8(+) T cells can also utilize TRAIL to kill virally infected cells. Therefore, we herein examined the importance of TRAIL to influenza-specific CD8(+) T cell immunity and to the control of influenza virus infections. Our results show that TRAIL deficiency increases influenza-associated morbidity and influenza virus titers, and that these changes in disease severity are coupled to decreased influenza-specific CD8(+) T cell cytotoxicity in TRAIL(-/-) mice, a decrease that occurs despite equivalent numbers of pulmonary influenza-specific CD8(+) T cells. Furthermore, TRAIL expression occurs selectively on influenza-specific CD8(+) T cells, and high TRAIL receptor (DR5) expression occurs selectively on influenza virus-infected pulmonary epithelial cells. Finally, we show that adoptive transfer of TRAIL(+/+) but not TRAIL(-/-) CD8(+) effector T cells alters the mortality associated with lethal dose influenza virus infections. Collectively, our results suggest that TRAIL is an important component of immunity to influenza infections and that TRAIL deficiency decreases CD8(+) T cell-mediated cytotoxicity, leading to more severe influenza infections.
Details
- Title: Subtitle
- CD8 T cells utilize TRAIL to control influenza virus infection
- Creators
- Erik L Brincks - Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USAArna KatewaTamara A KucabaThomas S GriffithKevin L Legge
- Resource Type
- Journal article
- Publication Details
- The Journal of immunology (1950), Vol.181(7), pp.4918-4925
- DOI
- 10.4049/jimmunol.181.7.4918
- PMID
- 18802095
- PMCID
- PMC2610351
- NLM abbreviation
- J Immunol
- ISSN
- 0022-1767
- eISSN
- 1550-6606
- Publisher
- United States
- Grant note
- R21 AI072032 / NIAID NIH HHS R21 AI072032-02 / NIAID NIH HHS R21 AI072032-01A1 / NIAID NIH HHS
- Language
- English
- Date published
- 10/01/2008
- Academic Unit
- Microbiology and Immunology; Pathology
- Record Identifier
- 9984047718802771
Metrics
29 Record Views